Colon Cancer Update Review
An updated information of colon cancer is revealed here!
Overview of Colon Cancer
It is important to recognize the increased risk for cancer in patients with hereditary cancer syndromes, but by far the most common form of colon cancer is sporadic in nature, without an associated strong family history.
Although the cause and pathogenesis of adenocarcinoma are similar throughout the large bowel, colon cancer, significant differences in the use of diagnostic and therapeutic modalities separate colonic from rectal cancers. This distinction is largely due to the confinement of the rectum by the bony pelvis. The limited mobility of the rectum allows MRI to generate better images and
colon cancer
Colon Cancer Recurrent Rates
Recurrence rates of colon cancer, determined by number of involved nodes and serosal penetration, as defined by the Gastrointestinal Tumor Study Group adjuvant trial, agree with most modern single-institution series. The median survival time from the clinical detection of metastases is 6 to 8 months.However, larger reviews of patients with metastatic disease do not represent survival statistics applicable to smaller, more selected series. For instance, numerous single-institution treatment series have consistently selected smaller groups of patients with either isolated liver metastases or isolated pulmonary metastases from colon and rectal carcinoma, who have been shown to have long-term survival regardless of treatment response. If patients are diagnosed with minimal metastatic disease isolated to a single organ and have no dysfunction (so-called Eastern Cooperative Study Group [ECOG] 0 performance status), median survival without any treatment at all may be between 2 and 3 years.If these “good biology” patients are accrued to treatment protocols and compared with historic controls, whatever treatment is being examined could inappropriately be touted as effective.
